Gene Therapy Improves Survival and Quality of Life of Dogs with Cancer

	Tweet

A new gene therapy has helped pet dogs with cancer live longer and could potentially improve the quality of life and survival of people with cancer, said the therapy’s developers. The results of the animal study will be presented at The Endocrine Society’s 90th Annual Meeting in San Francisco.

The single treatment works by increasing muscle strength and correcting common complications of cancer such as weakness, weight loss and anemia, said principal investigator Ruxandra Draghia-Akli, MD, PhD, researcher, VGX Pharmaceuticals Inc., The Woodlands, Tex.

Such complications occur in more than 50 percent of patients with cancer and, along with loss of appetite and fatigue, result in poor quality of life, she said. If cachexia—muscle wasting and severe weight loss - develops, it can prevent cancer-specific therapy from being given and may be a direct cause of death.

“With our type of gene therapy,” Draghia-Akli said, “we can ‘trick’ certain types of cells in the body to naturally produce specific hormones.” These hormones have a muscle-building, or anabolic, effect.

The therapy uses a nonviral DNA molecule, called a plasmid, which encodes for growth hormone-releasing hormone (GHRH). This stimulates the endogenous growth hormone and another growth substance, insulin-like growth factor-1 (IFG-1), which have anabolic effects.

The therapeutic process involves injecting the DNA fragment into a muscle and applying electroporation—short, mild, controlled electric fields—in the area of the injection. It opens the cell membrane pores and traps the DNA inside the cells, which allows the production of GHRH. This thwarts the body’s natural process of eliminating a foreign body, in this case the DNA molecule, Draghia-Akli explained.

The researchers tested the gene therapy in 55 companion dogs that had cancer and anemia and were receiving cancer treatment. Three months after the injection, 54 percent of the dogs had responded to gene therapy, as apparent on blood testing. Dogs that responded to therapy survived 84 percent longer, compared with dogs that did not respond to gene therapy and untreated control dogs that received a placebo injection.

Also, study data showed quality of life, especially appetite, dramatically improved with the gene therapy, and complications of chemotherapy, such as vomiting and diarrhea were greatly reduced,

VGX Animal Health Inc. plans to develop this product for companion dogs and cats. VGX Pharmaceuticals Inc. is also waiting for approval from the Food and Drug Administration to study the GHRH treatment in humans with cancer cachexia, Draghia-Akli said.

Founded in 1916, The Endocrine Society is the world’s oldest, largest, and most active organization devoted to research on hormones, and the clinical practice of endocrinology. Today, The Endocrine Society’s membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 80 countries. Together, these members represent all basic, applied, and clinical interests in endocrinology.

Source: Endocrine Society

RELATED STORIES:
Cancer Research Highlights   Teenagers and young adults more likely to survive cancer in Australia than in the USA   New attack on cancer forces cells to grow old & die   Fewer young men in Canada are being diagnosed with cancer   Pfizer’s Sutent improves survival in cancer study   9/11 firefighters have higher cancer risk: study   Scientists Find Key to Gene that Promotes Cancer Metastasis   Scientists Share Data about Malignant Hyperthermia   Young cancer researcher to meet the world’s best   Studies Investigate Health Care at the End of Life   Potential New Therapeutic Molecular Target to Fight Cancer   Many parents at-risk for cancer disclose genetic test results to children   Scientists devise targeted therapy strategy for rare form of childhood cancer   Anti-cancer compound found in beans, nuts, cereals   How Eating Red Meat Can Spur Cancer Progression   Research makes it possible to predict how cancers will respond to chemo   More Allergic Reactions to Widely-Used Cancer Drug   Cancer centers and high-volume hospitals may examine more lymph nodes in cancer patients   Nicotine promotes growth of established tumors   Fish oil reduces effectiveness of chemotherapy   New computational tool for cancer treatment   Lung cancer tied to family risk of other cancers

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]